The 21th annual congress of the German society for regulatory affairs (DGRA) will focus on the challenges of the relocation of the European Medicines Agency (EMA) to Amsterdam, the impact of the Brexit for the pharmaceutical industry, the use of "Big Data" in drug approvals and changes in German drug law.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.